All articles starting with R
22,461 articles
Riley Williams
Riley June Williams, Harrisburg, Pennsylvania woman convicted of civil disorder for the January 6, 2021 Capitol attack; charged but not convicted in Nancy Pelosi laptop theft; sentenced to 36 months, later pardoned by Trump.
Rilimogene galvacirepvec
Rilimogene galvacirepvec (PROSTVAC-V, V-PSA-TRICOM) is a recombinant vaccinia virus prime of the PROSTVAC prostate cancer vaccine, paired with fowlpox booster rilimogene glafolivec; phase III PROSPECT showed no survival benefit.
Riliprubart
Riliprubart (SAR445088, BIVV020, TNT020) is Sanofi's investigational humanized IgG4 monoclonal antibody inhibiting activated C1s in the classical complement pathway, studied in cold agglutinin disease and CIDP; its MOBILIZE phase 3 CIDP trial was stopped for futility in June 2026.
Rilke (Mercurian crater)
Rilke is an IAU-approved 86 km diameter impact crater on Mercury, centered at 45.2 degrees south latitude, catalogued as Gazetteer feature 5035 and studied in MESSENGER crater morphology surveys.
Rill (software)
Rill (rilldata/rill) is an open-source Apache-2.0 BI-as-code tool by Rill Data with DuckDB embedded by default, live OLAP connectors, Explore and Canvas dashboards, Rill Cloud, and MCP-based AI agent integration.
Rill erosion
Rill erosion is the removal of soil by runoff water concentrated into numerous small, generally parallel channels centimeters deep; untreated, it develops into gully erosion.
Rilmenidine
Rilmenidine (Hyperium) is an imidazoline I1-receptor agonist antihypertensive, 1–2 mg once daily, not available in the US; effective in mild-to-moderate hypertension with less sedation and no rebound than clonidine.
Rilo Kiley
Rilo Kiley: Los Angeles indie rock band (formed 1998) fronted by former child actors Jenny Lewis and Blake Sennett with Pierre de Reeder and Jason Boesel; albums on Barsuk, Saddle Creek, and Warner; split 2011, reunited 2025.
Rilonacept
Rilonacept (ARCALYST) is a subcutaneous IL-1α/IL-1β cytokine trap approved for CAPS, DIRA remission maintenance, and recurrent pericarditis; dosed 320 mg loading then 160 mg weekly, with injection-site reactions and upper respiratory infections as common adverse effects.
Rilotumumab
Rilotumumab (AMG 102) is Amgen's fully human monoclonal antibody neutralizing HGF to block MET signaling. Its phase 3 RILOMET-1 gastric cancer trial showed harm, and Amgen terminated all studies in November 2014.
Rilpivirine
Rilpivirine (RPV, TMC278), a diarylpyrimidine NNRTI for HIV-1, dosed 25 mg once daily with food; non-inferior to efavirenz in ECHO/THRIVE; also long-acting injectable with cabotegravir (Cabenuva).
Riluzole
Riluzole (Rilutek, Tiglutik, Exservan) is an antiglutamatergic drug for ALS, FDA-approved in 1995; it prolongs median survival by two to three months and remains the only globally approved disease-modifying ALS therapy.
Rilvegostomig
Rilvegostomig (AZD2936) is AstraZeneca's investigational monovalent bispecific humanized IgG1 antibody targeting PD-1 and TIGIT, with a reduced-Fc triple mutation and a TIGIT arm from Compugen's COM902, in Phase 3 NSCLC and other solid tumor trials.
Rilzabrutinib
Rilzabrutinib (Wayrilz, PRN1008), an oral reversible covalent Bruton's tyrosine kinase inhibitor by Sanofi, approved 2025-2026 in the US, EU, and UK for refractory adult immune thrombocytopenia.
Rim (firearms)
In firearms, the rim is the flanged lip at the base of a cartridge case that the extractor grips to pull the spent case from the chamber.
Rim brake
A rim brake is a bicycle braking system in which pads press directly against the wheel rim, the dominant brake for most of the 20th century.
Rim Jong Sim
Rim Jong Sim (림정심, born 1993) is a North Korean weightlifter, the only DPR Korean weightlifter with two Olympic golds (69 kg London 2012, 75 kg Rio 2016) and holder of 76 kg world records (124 kg snatch, 278 kg total).
Rim of the World
Rim of the World is a 2019 Netflix Original sci-fi adventure film directed by McG and written by Zack Stentz, about four misfit teens at a California summer camp who must carry a key to stopping an alien invasion 70 miles to JPL; released May 24, 2019.
RIM-116 Rolling Airframe Missile
The RIM-116 Rolling Airframe Missile (RAM) is a fire-and-forget surface-to-air missile developed by the United States and Germany for ship defense against anti-ship cruise missiles.
RIM-161 Standard Missile 3
The RIM-161 Standard Missile 3 (SM-3) is an exoatmospheric interceptor of the US Navy and Japan that destroys ballistic missiles in midcourse flight with a hit-to-kill kinetic warhead.
RIM-162 ESSM
The RIM-162 ESSM, or Evolved SeaSparrow Missile, is a medium-range ship-launched surface-to-air missile developed by an international consortium and in full US Navy use since 2004.
RIM-174 Standard ERAM
The RIM-174 Standard ERAM, designated Standard Missile 6 or SM-6, is a Raytheon-built, ship-launched multi-mission interceptor of the US Navy, first deployed aboard USS Kidd in November 2013.
RIM-66 Standard
The RIM-66 Standard, or Standard Missile, is a medium-range surface-to-air missile family for the United States Navy, entering service in 1967 to replace the Terrier and Tartar.
RIM-67 Standard
The RIM-67 Standard ER, also designated SM-2ER, is a two-stage ship-launched surface-to-air missile developed for the United States Navy as the extended-range member of the Standard Missile family.
RIM-7 Sea Sparrow
The RIM-7 Sea Sparrow is a radar-guided, short-range surface-to-air missile derived from the AIM-7 Sparrow, used since 1975 for ship self-defense against aircraft and cruise missiles.
RIM-8 Talos
The RIM-8 Talos was a long-range, ramjet-powered surface-to-air missile developed for the US Navy, serving aboard cruisers from 1958 until 1979, developed under Project Bumblebee.
Rim-Anum
Rim-Anum, also known as Rīm-Anum, was an Old Babylonian king of Uruk who took the throne during the southern revolt against Samsu-iluna of Babylon around 1742 BC.
Rim-like
Rim-like (InterPro IPR039032) is a protein family grouping RIM (Rab3-interacting molecule) scaffold proteins RIMS1-4 and piccolo, defined by zinc finger, PDZ, and C2 domains and a role in synaptic vesicle docking, priming, and calcium-channel recruitment at presynaptic active zones.
Rim-Sin I
Rim-Sin I (Rīm-Sîn) was the last king of the Larsa dynasty in southern Babylonia, reigning about 1822 to 1763 BC, the longest reign of any known Mesopotamian ruler.
Rim-Sin I's conquest of Isin
Rim-Sin I's conquest of Isin was the capture of Isin by Larsa around 1793 BC, ending the dynasty of Isin and making Rim-Sin ruler of all southern Babylonia.